SMART Apps

We have also developed four SMART-on-FHIR apps for natural product drug interactions of importance. Click here to view our available apps. A small description of each app is listed below.

Publications

Chapin MR, Kane-Gill SL, Li X, Abanyie K, Taneja SB, Egbert S, Paine MF, Boyce RD. Part 1: Evaluation of Pediatric Cannabis-Drug Interaction Reports. Pharmacol Res Perspect. 2025 Feb;13(1):e70046. doi: 10.1002/prp2.70046. PMID: 39719830; PMCID: PMC11668912.

Chapin MR, Kane-Gill SL, Li X, Abanyie K, Taneja SB, Egbert S, Paine MF, Boyce RD. Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System. Pharmacol Res Perspect. 2025 Feb;13(1):e70047. doi: 10.1002/prp2.70047. PMID: 39719832; PMCID: PMC11668913.

Li X, Ndungu P, Taneja SB, Chapin MR, Egbert SB, Akenapalli K, Paine MF, Kane-Gill SL, Boyce RD. An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021. Clin Transl Sci. 2023 Jun;16(6):1002-1011. doi: 10.1111/cts.13505. Epub 2023 Mar 20. PMID: 36861661; PMCID: PMC10264943.